Safety, Tolerability and Pharmacokinetics After Continuous Infusion of KAND567
Clinical trial NCT06030375 · COMPLETED
Trial details
- NCT number
- NCT06030375
- Sponsor
- Novakand Pharma AB
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-17
- Primary completion
- 2020-04-27
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.